Profile: 3M BioApplications is a part of the 3M Inc. focusing mainly on chromatography media.
3M is a world leader in MDI technology and was the first company to successfully use HFA-134a as a propellant. This is one of the important, enabling technologies for the transition of patients from CFC-MDIs which are being phased out under the terms of the Montreal Protocol due to the damaging effects of CFCs on the ozone layer. 3M Pharmaceuticals launched AiromirTM, the world's first CFC-Free MDI in 1995. Airomir, now approved in over 45 countries around the world, contains albuterol, the most popular drug prescribed to relieve the symptoms of an asthma attack. In the United Kingdom, 3M also recently launched QVARTM, an HFA formulation of beclomethasone, an inhaled steroid that helps to reduce the inflammation of asthma in the lungs.<<
There may be more within this diversified company, w/o stretching too much.E.g.
Quote: ________________________________________ In short, your definition of biotech is evidently narrower than mine. ________________________________________
Yes, I differentiate between large pharmaceutical companies and biotechnology companies (as does S&P, various stock indices and ETFs, etc.).
MNTA is in my view a biotechnology company and is included in the following biotechnology industry listing:
ABT, PFE, NVS, AGN and PKI are in my view large pharma or medical device companies:
http://biz.yahoo.com/ic/510_cl_pub.html (although the Yahoo yahoos messed up their listing including a few pink sheet stocks as Major Drug Mfgs., but you get the idea) or
So I take it that you do not currently see any “Biotech Values” companies (as traditionally categorized, in my view) worthy of your investment dollars that are not large pharma companies (other than MNTA, a company you know I like and feel you did excellent research on)? I only bring this up because you recently mentioned your My Stocks list and I only noticed MNTA as what many would consider a traditional biotech holding and in recent years rarely see you post about a traditional biotechnology company that you actually liked as an investment. Most of the other posters on your board appear to be investors in traditional biotechnology companies. I was just curious and it’s absolutely fine with me if you don’t currently own another traditional biotech. After all there are over 10,000 other US publicly traded non-biotech companies to choose from and the world’s financial markets currently appear riskier and investors more risk adverse than normal.